📊 Indices and Companies
-
The session in Europe is running fairly quietly, characterized by cosmetic reshuffling between key markets and sectors.
-
Futures on the broad Stoxx 50 (EU50) gain 0.2%. Futures on the German DAX (DE40), Dutch AEX (NED25), and Spanish IBEX 35 (SPA35) are trading flat. Losses are more visible in France (FRA40: -0.15%) and Switzerland (SUI20: -0.35%). The WIG20 is down about 0.9%.
-
Friday's Anthropic results (a 14-fold jump in quarterly revenue) are driving gains in the semiconductor sector (ASML: +2.7%, STMicro: +3.9%, Infineon: +0.8%, Soitec: +2.7%). Meanwhile, capital is mainly flowing out of software (SAP: -0.8%) and consumer goods (Tesco: -2%, Nestle: -2%, L’Oréal: -1%).
-
AstraZeneca halted clinical trials of the lung cancer drug volrustomig because it did not prove more effective than existing therapies. Despite this, the company's shares are gaining about 0.8% thanks to positive test results for the drugs Tagrisso and Enhertu. The firm plans further studies on volrustomig in the treatment of other cancers.
-
Argenx shares jumped 11% following positive Phase 3 trial results for VYVGART Hytrulo in myositis. The drug met its primary endpoint in patients with IMNM, enabling a regulatory submission. Although statistical significance was not reached in the dermatomyositis (DM) subgroup, analysts view the results as very promising.
Volatility in the Stoxx 50 is concentrated in the technology sector. Source: XTB Research, xStation5 data
The Stoxx 50 contract paused near record highs, constrained by a nearly overbought RSI. Source: xStation5
🌍 Economy and Geopolitics
-
Sources close to media outlet Al Arabiya indicate the possibility of extending the 60-day agreement between Iran and the US. Furthermore, the Iranian Ministry of Foreign Affairs reported talks with Qatar, which is expected to play a key role in de-escalation efforts. Meanwhile, Donald Trump emphasized that the primary goal for the US is to strip Iran of any chance of acquiring a nuclear weapon.
💱 Currencies, Commodities, and Cryptocurrencies
-
The US dollar maintains its losses from the Asian session (USDIDX: -0.15%), while Antipodean currencies continue to gain the most from rising risk appetite (AUDUSD: +0.7%; NZDUSD: +0.75%). EURUSD briefly crossed the psychological 1.1600 level, but is currently trading just below this resistance (+0.3%).
-
Crude oil futures returned to gains (OIL: +0.6% to $89.20 per barrel), while European natural gas futures trimmed their bullish opening slightly (NATGAS.EU: +1.6%; previously +2%).
-
Precious metals accelerate thanks to sustained dollar weakness. Gold (GOLD) gains 0.6% to $4,400 per ounce, while silver (SILVER) adds 1.5% to $65.70 per ounce. Platinum and palladium futures also remain in the green.
-
Bitcoin gains 1.15% to $63,680, and Ethereum adds 1.7% to $1,908.
The P/E ratio between the European Stoxx 50 and the US S&P 500 jumped during the ongoing earnings season. Source: XTB Research
Canadian CPI slightly higher than expected 🔼 USDCAD reacts
Gold gains and returns to $4,400 🗽 Are precious metals betting on a dovish Fed?
🟠Is there a shortage of physical copper?
Chart of the day: EURUSD eyes 1.1600! The dollar season is over?
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
